Soleno Therapeutics, Inc.
7 clinical trials · Sponsor
◉ Watch Soleno Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome (NCT07450664) | Soleno Therapeutics, Inc. | 2025-11-26 |
| Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome (NCT05701774) | Soleno Therapeutics, Inc. | 2023-01-31 |
| An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities (NCT05532020) | Soleno Therapeutics, Inc. | 2023-01-01 |
| An Open-Label Study of DCCR Tablet in Patients With PWS (NCT04086810) | Soleno Therapeutics, Inc. | 2019-10-01 |
| PWS Outcomes Assessment Study (NCT04102839) | Soleno Therapeutics, Inc. | 2019-07-15 |
| Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period (NCT03714373) | Soleno Therapeutics, Inc. | 2018-10-01 |
| A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome (NCT03440814) | Soleno Therapeutics, Inc. | 2018-05-09 |
Track Soleno Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.